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Abstract

Background:
Objectives: This study evaluated the weight trajectories of Roux-en-Y gastric bypass (RYGB)
patients and identified the distinct clinical, behavioral, and demographic features of patients by
trajectory.
Setting: Data from 2918 RYGB patients from a comprehensive medical center between January
2004 and November 2016 were included.
Methods: This retrospective, observational study used data for RYGB patients up to 7 years
postsurgery. Group-based trajectory models were fitted for percentage weight change. Variables
evaluated by trajectory included age, sex, diagnoses, medications, smoking, presurgical body mass
index, preoperative weight loss, and early postoperative weight loss.
Results: Of 3215 possible patients, 2918 (90.8%) were included (mean age = 46.2 ± 11.2 yr,
body mass index = 46.9 ± 7.9 kg/m2 at the time of surgery). Three weight change trajectories
were identified (above average, average, and below average). Mean percentage weight change at
the nadir for the above average group was −42.85% ± 5.7% compared with −31.57% ± 5.0% in
the average group and −22.74% ± 5.7% in the below average group. Compared with the above
average group, the below average group was more likely to be male (odds ratio [OR] = 2.40,
P < .0001) and have diabetes (noninsulin users, OR = 2.08, P < .0001), but less likely to have
a smoking history (OR = .62, P = .0007) or take sleep medications (OR = .50, P = .005). Below
average group patients had a lower BMI at the time of surgery (OR = .96, P < .0001). Lower
initial weight loss postsurgery was associated with a greater chance of a poorer weight outcomes
(OR = 1.64, P < .0001).
Conclusion: Select clinical, demographic, and behavioral factors may increase or decrease the
chance for better weight loss after RYGB. (Surg Obes Relat Dis 2018;xxx:xxx–xxx.) © 2018
American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.
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For many patients with obesity, weight loss surgery conveys durable benefits that span improvements in physical and mental health, longevity, and quality of life [1–
E-mail address: michellele@pcom.edu (M.R. Lent).
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6]. However, weight change trajectories after surgery are
heterogeneous [1]. In 2013, Courcoulas et al. [1] modeled weight change trajectories of surgery patients through
3 years postoperatively and found that approximately 23%
of Roux-en-Y gastric bypass (RYGB) patients did not
achieve or sustain >25% total weight loss.
In the era of precision medicine [7], better understanding the demographic and clinical features of weight loss
surgery patients who experience poorer outcomes would
help to guide clinical care. To date, body mass index (BMI)
at the time of surgery and age are consistently associated with weight change postoperatively [8–12]. Certain
personality disorders or traits, eating pathology and psychiatric disorders, diabetes status, and preoperative weight
loss may also relate to postoperative weight loss, though
findings are less consistent regarding these relationships
[8,9,13–17]. Wood and colleagues [16] found preoperative
insulin use, history of smoking, and a high number of prescribed medications to relate to better long-term weight
loss, while hyperlipidemia was associated with poorer outcomes. Finally, early postoperative weight loss (initial 3–6
mo) is associated with greater weight loss 2 years after
RYGB [18].
This study’s objective was to evaluate the determinants
of weight change trajectories in a cohort of RYGB patients followed for 7 years postsurgery. Specifically, this
study aimed to (1) replicate weight loss trajectory modeling conducted previously [1] but for a longer timeframe
and (2) compare the demographic, behavioral, and clinical
factors associated with the weight-change trajectories, including preoperative and early postoperative weight loss,
diagnoses, and medication use.

36

Methods

37

Participants

38

De-identified electronic health record (EHR) data were
obtained for patients who completed weight loss surgery
from January 2004 to November 2016 at a large, rural, comprehensive medical center. Inclusion criteria were
as follows: (1) completion of primary RYGB, and (2)
weight data available in the EHR preoperatively and postoperatively (up to year 7). Patients who were <1 year
postsurgery were excluded. The preoperative program for
weight loss surgery involves a 6- to 12-month multidisciplinary curriculum with the goal of 10% weight loss [19].
Postoperatively, patients are scheduled for follow-up visits
1 and 2 weeks after surgery; 2, 5, 8, and 12 months; and
yearly thereafter.
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Outcome measures
The primary study outcome was the percentage of initial weight change [1], measured longitudinally through

7 years. Weights were collected from the EHR from all
encounters across the health system.
Demographic variables included patients’ age, sex, and
race. Clinical variables collected at the time of surgery
were diagnoses (i.e., mood disorders, osteoarthritis, diabetes, nondependent drug use, hypertension, sleep disorders, back or soft tissue disorders, fibrosis, and dyslipidemia as documented by International Classification of
Disease code), use of certain medications and total medications prescribed, and surgical BMI.
Behavioral factors included history of smoking, presurgical weight loss (time of initial consult to day of surgery),
and early postoperative weight change (percentage weight
change from day of surgery through postsurgery month
6).

54

Statistical analyses

69

Descriptive statistics characterized the cohort at the time
of surgery (mean and standard deviation for continuous
variables and frequency for categorical variables).
To account for heterogeneity of postsurgery weight
change patterns, group-based trajectory models (GBTM)
[20] with time as a polynomial trend (6 mo postsurgery
through up to 7 yr postsurgery) were fitted for the percentage weight change from baseline. Given a minimum of
1% sample inclusion per trajectory [1], Bayesian criterion
determined the best model fit. Percentage weight change
up to 7 years postsurgery was plotted from postoperative
month 6 for each trajectory. To identify factors associated
with group membership, preoperative factors and weight
change within 6 months postsurgery were linked to the
trajectories by simultaneously fitting a multinomial logistic regression within the GBTM.
Given the large number of baseline covariates, a selection procedure was implemented. From the initial GBTM,
each patient was assigned the trajectory corresponding to
the highest membership probability. A multinomial logistic regression model was fit using stepwise selection, erring
on the side of including more variables in the model. Finally, the reduced set of baseline covariates was entered
into the GBTM to fit the final model. Model results are
reported using odds ratios (ORs) and 95% confidence intervals (CIs).
The trajectory assignment was repeated for the final
model to permit characterizing the trajectory patterns.
Analysis of variance was conducted to test the differences
in continuous variables, and Pearson χ 2 tests were performed to test the independence of categorical variables
in the 3 subgroups. Analyses were performed using SAS
9.4. Results were considered significant at P < .05. The
health system’s institutional review board approved this
study.
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Table 1
Number of Roux-en-Y gastric bypass patients with weight data at each
postsurgery year (N = 2918).
Q6

Postsurgery
year

Frequency

Total
eligible

Percent
(N)

1
2
3
4
5
6
7

2399
1738
1714
1455
1244
1049
586

2918
2835
2519
2140
1778
1435
1019

82.2
61.3
68.0
68.0
70.0
73.1
57.5

∗ Weight

Weight
change %∗
−31.1
−31.2
−28.7
−26.9
−25.5
−24.6
−24.5

(8.1)
(10.5)
(10.8)
(11.2)
(11.6)
(11.8)
(12.0)
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Results
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Of 3215 possible eligible RYGB patients, 2918 patients
(90.8%) had a weight in the EHR at postsurgery years 1
through 7. Data available for analyses at each postoperative
year are in Table 1. At the time of surgery, patients were a
mean age of 46.2 ± 11.2 years with a mean BMI of 46.9
± 7.9 kg/m2 .
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Weight change trajectories
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Mean percentage weight change for the above average
group was −28.43% ± 5.69%; −24.38% ± 4.37% in the
average group, and −20.13% ± 4.33% in the below average group.
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Demographic characteristics

130

Characteristics by trajectory group are in Table 2. Compared with the above average group (Table 3), patients
in the below average group were more likely to be male
(OR = 2.40, CI = 1.63–3.51, P < .001).

131

Clinical characteristics

135

Compared with the above average group, the below
average group (Table 3) had lower BMI at the time of
surgery (OR = .91, CI = .90–.93, P < .0001). Below average group patients were less likely to take sleep medications (OR = .51, CI = .32–.81, P = .005) but more likely to
have diabetes (noninsulin users, OR = 2.08, 1.46–2.96, P
< .0001).
No significant differences between trajectory groups
were identified regarding number of medications or diagnoses of fibrosis, osteoarthritis, iron deficiency, sleep disorders, back or soft tissue disorders, or psychiatric disorders
at the time of surgery (P > .05, Table 3).

136

Behavioral factors

148

Below average group patients were less likely to smoke
(OR = .62, CI = .47–.81, P = .0007). Mean preoperative
and early postoperative weight changes by group are in
Table 2. No significant relationship was found between preoperative weight change and postoperative weight trajectories (P > .05). Smaller weight loss in the first 6 months
postsurgery was associated with greater chance of a poorer
long-term weight outcome (OR = 1.64, CI = 1.57–1.70,
P < .0001).

149

Discussion

158

This study identified 3 distinct weight loss trajectories
up to 7 years after RYGB. Our modeling resulted in fewer
trajectories compared with a previous study that identified
5 trajectories [1], which is likely due to differing study
durations, the data used, and statistical approaches. While
almost half of our RYGB patients sustained a successful
amount of weight at postoperative year 7 (25–30%), the
remaining half equally either sustained an above average
amount (≥40%) or a below average amount (≤20%) after
reaching their weight loss nadir.
Comparison of the demographic and clinical characteristics of the 2 most divergent weight loss outcomes (above
average versus below average) led to the identification of
several distinguishing characteristics. First, males were >2
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change % from time of surgery.

Fig. 1. Weight change trajectories in Roux-en-Y gastric bypass patients
(N = 2918) up to 7 years postoperatively.

107

3

Through evaluation of the BIC criterion and visual fit, 3
weight-change trajectories were best modeled with 2 quartic and 1 cubic polynomials (Fig. 1). Group 1 (n = 818,
28%) achieved a weight loss nadir of −42.85% ± 5.68%
at 24 months postsurgery and −38.50% ± 7.37% weight
loss at postsurgery year 7 (“above average” group). Group
2 (n = 1307, 45%, “average” group) achieved a weight loss
nadir of −31.57% ± 5.00% at 15 months postsurgery and
−24.06% ± 7.48% weight change at postsurgery year 7.
Group 3 (n = 793, 27%, “below average” group) achieved
a weight loss nadir of −22.74% ± 5.66% at 12 months
postsurgery and −12.67% ± 8.41% weight loss at postsurgery year 7.
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Table 2
Demographic, clinical, and behavioral factors of Roux-en-Y gastric bypass patients by weight change trajectory group (N = 2918)∗ .

Male sex, n (%)
Smoking history, n (%)
Age at surgery, yr, mean (SD)
BMI at surgery, kg/m2 , mean (SD)
Presurgical BMI change, kg/m2 , mean (SD)
Early postoperative weight change (0–6 mo %),
mean (SD)
Nondependent drug/alcohol use N (%)
Diabetes
Hypertension
Dyslipidemia
Fibrosis, n (%)
Iron deficiency, n (%)
Osteoarthrosis and allied disorders
Disorders of the back
Soft tissue disorders
Depression
Sleep disorders
Any diabetes medication use
Insulin use
Bupropion
Total medications (>12)

Below average
(n = 793)

Average
(n = 1307)

Above average
(n = 818)

P value†

176 (22.2)
391 (49.3)
48.7 (11.0)
46.4 (7.9)
−5.6 (5.1)
−20.1 (4.3)

260 (19.9)
646 (49.4)
45.5(11.0)
46.4 (7.8)
−4.8 (5.3)
−24.4 (4.4)

133 (16.3)
470 (57.5)
43.2 (10.9)
48.1 (7.9)
−3.8 (5.7)
−28.4 (5.1)

<.01
<.001
< 0.0001
<.0001
<.0001
<.0001

31 (3.9)
373 (47.0%)
443 (55.9%)
362 (45.7%)
223 (28.1)
107 (13.5)
170 (21.4%)
63 (7.9%)
42 (5.3%)
238 (30.0%)
140 (17.7%)
222 (28.0%)
145 (18.3%)
69 (8.7%)
377 (47.5%)

76 (5.8)
480 (36.7%)
654 (50.0%)
538 (41.2%)
339 (25.9)
170 (13.0)
305 (23.3%)
136 (10.4%)
71 (5.4%)
351 (26.9%)
224 (17.1%)
244 (18.7%)
213 (16.3%)
108 (8.3%)
588 (45.0%)

69 (8.4)
223 (27.3%)
344 (42.0%)
285 (34.8%)
214 (26.3)
96 (11.7)
204 (24.9%)
84 (10.3%)
53 (6.5%)
244 (29.8%)
138 (16.9%)
122 (14.9%)
92 (28.0%)
100 (12.2%)
346 (42.3%)

<.001
<.001
<.001
<.001
.52
.54
0.25
.15
.51
.19
.91
<.001
<.001
<.01
.11

SD = standard deviation; BMI = body mass index.
∗ At time of surgery unless otherwise noted.
† Analysis of variance for continuous variables; χ 2 test for categoric variables.
Table 3
Demographic, clinical, and behavioral factors associated with weight trajectory membership (N = 2918).

Age, yr
Sex, male
Smoking history, yes
BMI, kg/m2 (time of surgery)
Early postoperative weight
change (0–6 mo, %)∗
Depressive disorder
Sleep medication
Diabetes, no insulin
Diabetes, insulin

Below average versus
above average OR
(95% CI)

P value

Average versus above
average OR (95% CI)

P value

1.00 (.99–1.02)
2.40 (1.64–3.51)
.62 (.47–.82)
.91 (.90–.93)
1.64 (1.57–1.70)

.81
<.0001
.0007
<.0001
<.0001

1.01 (.99–1.02)
.71 (.57–.89)
.71 (.57–.89)
.94 (.93–.95)
1.25 (1.21–1.28)

.26
.0003
.003
<.0001
<.0001

.98 (.72–1.33)
.50 (0.31–.80)
2.08 (1.46–2.96)
1.23 (.81–1.88)

.89
.005
<.0001
.33

.80 (.63–1.03)
.86 (.61–1.23)
1.44 (1.08–1.94)
1.28 (.90–1.81)

.08
.43
.02
.17

OR = odds ratio; CI = confidence interval; BMI = body mass index.
Adjusted results from group-based trajectory modeling.
∗ Inverse relationship given that lower weight loss is associated with risk of below average group.
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183

times as likely to have below average outcomes. Though
we had fewer males than females in our cohort, similar
findings were reported in male gastric banding patients
over aged ≥50 years [12]. Unlike previous studies, we did
not find older age to be a risk factor for poorer weight loss
[8,10,16], which may relate to the long study timeframe.
Future studies could evaluate sex and age in patients who
undergo sleeve gastrectomy, a procedure that is rising in
popularity.
Second, patients with a higher BMI at the time of
surgery were more likely to experience better BMI change

over the study period, which mirrors the findings of several
previous studies [21,22]. Higher BMI may be associated
with greater co-morbidity, which may provide greater motivation to adhere to the postoperative diet and lifestyle in
the long term. However, other studies reported higher BMI
to predict poorer weight loss, but these studies primarily used percentage excess weight loss to evaluate weight
change, which is influenced by initial BMI [8,16,21].
Third, the use of certain medications was associated
with weight change. Patients with diabetes who did not
use insulin were >2 times as likely to experience below
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average weight loss. Notably, insulin use appeared to attenuate this risk. This finding adds to the mixed findings on
diabetes and long-term weight change after RYGB [8,16].
Patients using sleep medications were 50% less likely to
experience poor trajectories. Patients using sleep medications may be less likely to rise during the night, providing
fewer opportunities for calorie consumption. Additionally,
these patients could be more rested, providing greater motivation to engage in healthy eating and lifestyle behaviors.
Several behavioral factors were evaluated in regard to
weight outcomes, including preoperative and early postoperative weight loss and smoking history. We did not find a
relationship between preoperative weight change and postoperative weight outcomes. A previous prospective, randomized trial found patients in a preoperative program with
the goal of 10% weight loss achieved greater percentage
excess weight loss at 3 months postsurgery compared with
controls with no preoperative weight loss expectation [23].
Physician-supervised preoperative weight loss is strongly
recommended, if not required, as a prerequisite to surgery
in many programs [24]; however, our findings do not support the clinical relevance of this recommendation as it
relates to a patient’s ability and readiness to implement behavior change. Additional prospective, randomized studies
are needed to investigate the direction of the potential relationship between preoperative weight loss and long-term
outcomes.
In our study, greater weight loss within the initial 6 postoperative months decreased the likelihood of poorer weight
outcomes. Manning et al. [18] also found initial weight loss
velocity after RYGB to predict better weight loss. Collectively, our findings suggest that clinically, this initial period
of rapid weight loss may be a target for future interventions. While diet during the first 3 postoperative months is
largely dictated by the staged dietary progression [25], patients can exert more choice regarding level of adherence
to the recommended long-term diet during postoperative
months 3 to 6. Future studies could evaluate the impact
of additional behavioral support during this critical weight
loss time on dietary adherence and long-term weight outcomes. Finally, patients with a history of smoking were
less likely to have below average long-term weight loss
(38%). A history of smoking may be protective in that
patients may be able to apply the experience and skills
gained to achieve smoking cessation to behavior change
for long-term weight reduction.
Our study had several strengths, including the long timeframe for some patients, the inclusion of all available
weight data from the EHR, and the wide range of demographic, behavioral, and clinical factors explored in relation
to weight trajectories. Our study was limited, however, by
the retrospective design, homogeneity of our cohort, fewer
patients for inclusion at the later postoperative years, and
the inclusion of only 1 procedure type (RYGB).

5

Conclusion

250

In summary, certain RYGB patients may be at risk for
less robust long-weight loss. These patients, however, still
lose clinically meaningful amounts of weight and may experience the other well-documented benefits of surgery,
such as improvements in co-morbid conditions and quality of life [3–5,26]. Study findings can help to inform
patient–provider discussions surrounding postoperative expectations after RYGB and better guide clinical care.
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